Dr Maycock in a draft letter stated that the warning on the Hemofil labels overstated the risks and was chosen to afford Travenol maximum protection given that plasma and concentrate were tested in a proper manner by RIA.
Linked evidence
Chronology Information
Date:
Chapter/issue
Pharmaceutical Companies
Key Person(s)
Sir William Maycock